Response
TO LITHIUM NETWORK

We are glad to announce that Zoé Virion (INSERM Transfert) has joined r-LiNK as new project manager – welcome! Zoé holds a PhD in microbiology from Paris Descartes University and an advanced Master in Biotech & Pharma Business Management from Grenoble School of Management. Before arriving at Inserm Transfert in February 2022, she completed a postdoctoral fellowship at Sanofi Pasteur in Canada (Toronto), then was a project manager for the training of medical representatives in immunology at AbbVie. We wish Zoé great success in her new duties and responsibilities.

Karthik Chary (Newcastle University) and colleagues’ recent work on « Multi-Centre patients receiving lithium treatment for bipolar disorder: 7Li-MRI optimization using a physiologically representative phantom » will be presented at the ISMRM & SMRT annual meeting. Their digital poster participates in the poster session « Molecular Imaging & X-Nuclei: Applications » on Tuesday, 18 May 2021 at 13:00 UTC.”

The r-LiNK community successfully held a virtual meeting on March 18th and 19th. On this occasion, the r-LiNK partners reviewed the progress of the project and discussed the next steps. The ongoing pandemic still affects study processes in all countries, but nonetheless a number of tasks are progressing well.
We are very proud to announce that so far 38 patients have been included in the study and more will be included within the next days!

We are proud to announce that we have included our first patient on the 10th January 2020 in Dresden, Germany

Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative.

by Scott et al. International Journal of Bipolar Disorders

The R-LiNK project NewsR-LiNK 1st Annual meetingMarch 28-29, 2019R-Link partners met in Gothenburg for the 1st Annual meeting. It was the opportunity to review the progress of the project and discuss the next steps, in presence of members of the External Advisory…